De En Es It
16 YEARS OF INTERNATIONAL CLINICAL EXPERIENCE IN TRANSPLANTATION OF HUMAN EMBRYONIC/FETAL STEM CELLS. REVIEW
THE WORLDS LARGEST CLINICAL EXPERIENCE IN EMBRYONIC STEM CELL TRANSPLANTATION FOR VARIOUS DISEASES AND CONDITIONS

Home
About EmCell
EmCell Therapy
Our Experience
List of Diseases:
Oncology
Diabetes Mellitus
Nervous System
Aging Problems
Immune Deficiency
Endoscopic Treatment of Liver Diseases
Investment Projects
Clinical Trials
Congresses and Conferences
Mail Center

Acute lymphoblastic leukosis

List of diseases > Oncology > Case reports

Acute lymphoblastic leucosis

Case Report

The patient feels sick from October 1992, i.e. the time of appearance of subfebrile temperature, pain in the right shoulder, feeling of heaviness in the left hypochondrium, general weakness. On examination, changes were revealed in blood counts. Upon consultation by hematologist, the patient was examined and treated for 9 days at the Department of Hematology of the Regional Hospital, and then he was transferred with the diagnosis of acute lymphoblastic leukosis, to the Clinic for Hematology of the Research Institute for Hematology and Blood transfusion with the diagnosis of acute lymphoblastic leukemia.

On admittance: pale and clean skin and mucosa, enlarged postercervical (up to 1x1 cm) and submaxillary (up to 2.0x1.0 cm) lymph nodes; other lymph nodes normal. Pulse rate is 100 beats/min, rhythmic. Cardiac sounds are clear, with correct melody of cardiac activity. Vesicular respiration. The abdomen is soft and painless on palpation. Bowel parts normal. Liver and spleen are not enlarged.

Total blood count and the myelograms are given in Tables 1,2.
The following treatment was prescribed: 2 mg onkovin intravenously (administered twice); 7.5 mg carminamycin intravenously (administered twice), daily 50 mg mercaptopurine and 60 mg prednisolone. Symptomatic therapy included metacin, vikalin, asparcam.

After 8 days, patient developed profound pancytopenia (Table 1). His condition was assessed as critical: acute weakness, palpitation, dyspnea on insignificant loads. Hematopoietic cells of human fetal liver were transplanted intravenously: sample E-325-K, embryo age 8 weeks; cells count 20.106/ml; volume of administered tissue 1.5 ml; CFU-GM, 23.2.103. The volume of transplanted cells amounted to 40% of the total mass of this sample stored in cryobank.

The patient tolerated transplantation well; no reactions were reported during transplantation. Syndrome of early posttransplantation improvement of general condition was not expressed. By the 5th day, the patient demonstrated decreasing weakness, improved general condition, and increased amount of motions. On 11th day, indices of peripheral blood cell composition were normalized. On the 20th day, a course of cytostatic therapy was started: onkovin, L-asparaginase, prednisolone; this course was completed when clinical and hematological remission developed; condition of the patient during the treatment was good.

Bone marrow indices: patient M., suffering from acute lymphoblastic leukosis

Transplantation: December 1, 1992

Date
Indices
17.11.1992 21.01.1993 10.03.1993
Amount of megakaryocytes/mm 0 50 0
Amount of myelokaryocytes/mm decreased cell amount 62650 13750
Blasts 85 3.5 4
Promyelocytes:
neutrophilic
0 2.5 1
Myelocytes:
neutrophilic
eosinophilic
0.5 7.5
6
1
Metamyelocytes:
neutrophilic
eosinophilic
  10
5
1
Stab
neutrophilic
eosinophilic
1 12 9
Segmented
neutrophilic
eosinophilic
basophilic
0.5
0.5

15
0
1

23
2
1
Monocytes 2 2.5 4
Lymphocytes 7 6 8
Plasmatic cells     1
Pronormocytes   1.5 1
Normocytes      
basophilic
polyoxyphilic
oxyphilic

0.5
3
5
4
29
5
1
20
Luko-erythroid ratio 21:1 1.5:1 3:1
Maturation index of erythroblasts 1 0.83 0.8
Bone marrow index of neutrophils   0.71 0.4

Head of the Cell Therapy Clinic of National Medical University and Center "EmCell"
professor Alexander Smikodoub.


Blood indices in 17 years old patient M. suffering from acute leukemia

Date Erythrocytes
1012/L
Hemoglobin
g/l
Leukocytes
109/L
Thrombocytes
109/L
ESR
mm/h
Erythrocytes with
fetal Hb (%)
16.11.92 3.8 128 4.2 41 23 -
17.11.92 3.7 96 2.6 93 48 -
26.11.92 2.3 62 0.4 20 64 -
1.12.92 Cell Transplantation
3.12.92 2.8 75 1.3 78 44 .03
7.12.92 3.1 90 2.6 135 13 .12
8.12.92 2.4 80 4.0 - 13 .30
10.12.92 4.4 112 3.6 220 12 .42
17.12.92 4.3 128 10.2 344 4 .36
4.01.93 4.3 128 7.0 262 2 .40
15.03.93 5.1 112 4.9 330 10 .40

News
2008-09-25
Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and

Prof. Alexander I. Smikodub attended European Congress on Anti-Aging and Aesthetic Medicine held in Dusseldorf, Germany on September 11-14, 2008 as ...
more >
  Other news
 
Publications

25. Summary 2007

Participation in National and International Congresses, Conferences and Meetings III National Congress on Bioethics. Kyiv, Ukraine, October 8 – 11, 2007. IV Meeting of Transplantologists of Ukraine. ...
  Publications in English (1996-2003)
 
Patents

Medicinal preparation based on fetal cell suspension having immune substituting effect for patients with acquired immune ...
 
more
 
Copyright © 1999-2008 EmCell.com